
Izukanji Tembozi Sikazwe MD
CEO, Centre for Infectious Disease Research in Zambia
Join to View Full Profile
725 W Lombard StInfectious DiseaseBaltimore, MD 21201
Phone+1 410-706-7560
Dr. Sikazwe is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- University of MarylandFellowship, Infectious Disease, 2008 - 2010
- Good Samaritan Hospital of MarylandResidency, Internal Medicine, 2003 - 2006
- University of Zambia, School of MedClass of 2002
Certifications & Licensure
- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Differentiated Care for Improved Health Systems Efficiency and Health Outcomes in Zambia Start of enrollment: 2016 Mar 01
- Understanding Longitudinal Clinical Outcomes and Post-release Retention in Care Among HIV-infected Prisoners in Lusaka, Zambia Start of enrollment: 2017 Mar 16
- Evaluating Implementation Strategies to Scale-up Transdiagnostic Evidence-based Mental Health Care in Zambia Start of enrollment: 2020 Feb 25
Publications & Presentations
PubMed
- Announcing the Lancet Global Health Commission on artificial intelligence (AI) and HIV: leveraging AI for equitable and sustainable impact.Michael J A Reid, Benedette A Otieno, Alastair van Heerden, Izukanji Sikazwe, Solange L Baptiste
The Lancet. Global Health. 2025-04-01 - How can Africa sustain its HIV response amid US aid cuts?Wilbroad Mutale, Aggrey Semeere, Elizabeth A Bukusi, Dike Ojji, Francois Venter
The Lancet. HIV. 2025-03-20 - Africa's defining moment: the time to lead the HIV response is now.Mumbi Chola, Izukanji Sikazwe, Magda Robalo, Pokuaa Oduro-Bonsrah, Alex Coutinho
The Lancet. Global Health. 2025-03-11
Journal Articles
- Understanding Preferences for HIV Care and Treatment in Zambia: Evidence from a Discrete Choice Experiment Among Patients Who Have Been Lost to Follow-UpElvin H Geng, Izukanji Sikazwe, PLoS One
- Estimating the Real-World Effects of Expanding Antiretroviral Treatment Eligibility: Evidence from a Regression Discontinuity Analysis in ZambiaIzukanji Sikazwe, MD, PLoS One
Press Mentions
- Strengthening Health Systems to Better Fight Infectious Diseases in AfricaMay 28th, 2019
- CIDRZ Appoints Dr Izukanji Sikazwe as New CEO and DirectorJanuary 11th, 2017
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: